Analyst Report: MCHP
1. EXECUTIVE SUMMARY
Microchip fell 13.92% to $64.85 on Thursday 5 November 2026, in a session that ended before the company published its results. The cause was a semiconductor sell-off tied to the US midterm results and fears of a slower data-center buildout, with no company news behind the drop (CNBC, Quartz, TIKR). The fiscal Q2 release and December-quarter guidance arrived after the 4pm ET close, so they did not drive this session. They did give the stock a second problem: guidance for flat to down 3% sequential revenue and a lower gross margin, both below consensus, and the stock traded lower after hours (direction established, size varies by source). Volume of 44.0m shares was 4.66x the 50-session average. The decline widens a slide of 20.06% from the 29 October close, and the first full session reacting to the guidance is Friday 6 November.
2. THE CATALYST
Session of 5 November (before the results). Chip stocks fell for a second day. CNBC and Quartz reported that the iShares Semiconductor ETF fell close to 11%, its worst day since March 2020. Fox Business and Forbes attributed the sell-off to the midterm sweep and worries about AI regulation. CNN and Forbes reported that Texas's governor-elect campaigned on a temporary data-center moratorium and that an Ohio governor-elect backed a conditional one. The brief does not tie either to a dated policy action. AP reported Nvidia down 8% in the same session. TIKR, writing around 15:20 ET, said Microchip's 13% fall had no company news behind it.
After the close. The release and dividend notice were stamped 21:15 UTC (Yahoo Finance, timing inferred from feed timestamps).
| Item | Result | Source |
|---|---|---|
| Net sales | $1.622bn, up 42.2% year on year, up 9.2% sequentially | Microchip release via Yahoo Finance |
| August guidance midpoint | $1.604bn | Microchip release via Yahoo Finance |
| GAAP EPS | $0.68 | Microchip release via Yahoo Finance |
| Non-GAAP EPS | $0.97, $0.04 above guidance midpoint | MarketBeat |
| One-time revenue | About $53m, not expected to recur | MarketBeat |
| December-quarter revenue guide | Flat to down 3% sequentially, midpoint $1.606bn | Investing.com, MarketBeat |
| December-quarter non-GAAP gross margin | 64–65%, against 66.5% in September | Investing.com, MarketBeat, StockStory |
Sources describe the guide as below consensus on both lines. Consensus revenue appears as $1.62bn (Investing.com) and $1.61bn (MarketBeat). Against the facts panel's estimates of $0.95 EPS and $1.63bn revenue, reported non-GAAP EPS of $0.97 was ahead and revenue of $1.622bn was slightly below. After-hours declines were reported at 6% and 4% (Investing.com) and 2.96% and 4.33% (Chartmill). Only the direction is firm. Two of the three articles the research assistant tried to open returned only page navigation, so the release figures rest partly on page descriptions and secondary reporting.
3. COMPANY PROFILE
Microchip Technology develops, manufactures and sells embedded control solutions, mainly microcontrollers and mixed-signal microprocessors, for automotive, industrial, computing, communications and other end markets. It reports two segments, Semiconductor Products and Technology Licensing. It sits in the Technology sector, and the semiconductor peers tracked here are Micron, Nvidia, AMD, Intel, Broadcom and Marvell. Market capitalisation is $35.21bn, the dividend yield is 2.42%, and the forward P/E of 14.1 compares with a trailing P/E of 95.4. The quarter is labelled fiscal Q2 2027 by the company and calendar Q3 2026 by StockStory. The quarterly dividend of 45.5 cents is payable on 8 December 2026 to holders of record on 23 November (Investing.com).
4. DEEP DIVE ANALYSIS
Did fundamentals justify the move? The 5 November session fell on sector sentiment, so the fundamentals did not cause it. Microchip lost 13.92% against 17.46% for Micron, 17.26% for AMD, 16.43% for Marvell, 10.43% for Broadcom, 10.33% for Intel and 9.26% for Nvidia. The S&P 500 fell 4.36%. Microchip's fall sits in the middle of the group. TIKR said Intel's supply-related problems left it less exposed to the sell-off, and CNN linked Qualcomm's 4 November miss, blamed on higher memory costs, to the same theme.
The results added company-specific weight. Revenue beat the August guidance midpoint, yet the December guide implies a sequential decline at the midpoint, and about $53m of September revenue is not expected to recur. A drop of roughly 1.5 points in gross margin guidance is a larger concern for a company with high operating leverage. Inference: investors who held the stock through a sector panic received guidance that gave no reason to buy the dip.
Comparable episodes. Around 6 August, before the fiscal Q1 release, the stock fell 4.41% in the regular session and then rose 8.62% after hours on the guidance (Investing.com, approximate date). That pattern reversed this time. Barchart reported an 11% gain on a raised Q3 forecast on a 6 January of unconfirmed year, which shows how strongly the shares respond to guidance in either direction.
Bull case.
- Sales rose 42.2% year on year, and non-GAAP EPS beat the guidance midpoint.
- The forward P/E of 14.1 is low for the group.
- Analyst targets sit well above the price: Cantor $125, KeyBanc $135, B. Riley $98, Morgan Stanley $103 (StockAnalysis). Average targets are $105.92 from 26 analysts (StockAnalysis) and $97.71 from 24 analysts (MarketBeat). The brief found no target changes after the results, so these predate the guidance.
- The sell-off was driven by policy fears that the brief ties to no Microchip-specific event.
Bear case.
- The December guide is below consensus on revenue and gross margin.
- One-time revenue flattered the September quarter.
- Wells Fargo cut its target to $80 from $88 on 20 October and B. Riley cut to $98 from $108 on 22 October, so estimate pressure preceded the report.
- The sector sell-off could continue if data-center policy worries persist.
5. TECHNICAL SNAPSHOT
The $64.85 close sits below the 50-day average of $75.19 and the 200-day average of $79.12, and 38.1% below the 52-week high of $104.75 set on 8 May, though 37.2% above the 52-week low of $47.28 from 21 November 2025. The close is the lowest in the ten-session table, so no nearby support level is visible in these closes. The intraday low of $64.04 is the closest reference. Resistance is the prior close of $75.34, close to the 50-day average. The session opened at $74.58 and traded in a range from $64.04 to $75.79, with volume 4.66x the 50-session average, which indicates forced or heavy institutional selling. The 30 October session, at 19.8m shares, had already shown rising volume on the way down.
6. RISK FACTORS
- Guidance reaction. The after-hours decline varied between 2.96% and 6% across snapshots, and the Friday session sets the actual response.
- Sector policy risk. Data-center moratorium proposals in Texas and Ohio have no dated policy action in the brief, so the timeline is unknown.
- Memory costs and margins. Qualcomm blamed higher memory chip costs for its miss, and Microchip guided gross margin to 64–65%.
- Non-recurring revenue. About $53m of September sales will not repeat.
- Data gaps. The next earnings date is not in any source the research assistant could read. The facts panel's 5 November date has passed.
Dated events: dividend record date 23 November 2026 and payment date 8 December 2026.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). Price action depends on the first full session after the guidance and on whether the semiconductor sell-off continues. The $64.04 intraday low and the $75.34 prior close mark the near-term range. A further fall in the sector ETF would pressure the shares. A stabilising group would let the stock respond to its own results. Analyst target revisions after the guidance are the main item to watch, since none had appeared in the brief.
Medium term (1-3 months). The December-quarter margin and revenue outcomes drive direction. A forward P/E of 14.1 leaves room for recovery if revenue stabilises, and the 50-day average at $75.19 is the first level that would show a recovery. Estimate cuts after the guide would keep pressure on the shares.
Long-term thesis. The 42.2% year-on-year sales growth and the beat against the August guide leave the recovery narrative intact. The below-consensus guide on revenue and gross margin trims near-term earnings expectations. Whether that changes the longer view depends on whether the December flat-to-down guide marks a pause or a peak. The brief offers no evidence either way. This is analysis, not personal financial advice.